These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27460779)

  • 1. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia.
    Eriksson D; Goldsmith D; Teitsson S; Jackson J; van Nooten F
    BMC Nephrol; 2016 Jul; 17(1):97. PubMed ID: 27460779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.
    van Haalen H; Jackson J; Spinowitz B; Milligan G; Moon R
    BMC Nephrol; 2020 Mar; 21(1):88. PubMed ID: 32143582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review.
    Spinowitz B; Pecoits-Filho R; Winkelmayer WC; Pergola PE; Rochette S; Thompson-Leduc P; Lefebvre P; Shafai G; Bozas A; Sanon M; Krasa HB
    J Med Econ; 2019 Jun; 22(6):593-604. PubMed ID: 30813807
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Peng Z; Wang J; Yuan Q; Xiao X; Xu H; Xie Y; Wang W; Huang L; Zhong Y; Ao X; Zhang L; Zhao M; Tao L; Zhou Q;
    BMC Nephrol; 2017 Oct; 18(1):311. PubMed ID: 29029600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anemia correction with health related quality of life in patients not on dialysis.
    Alexander M; Kewalramani R; Agodoa I; Globe D
    Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.
    Fletcher BR; Damery S; Aiyegbusi OL; Anderson N; Calvert M; Cockwell P; Ferguson J; Horton M; Paap MCS; Sidey-Gibbons C; Slade A; Turner N; Kyte D
    PLoS Med; 2022 Apr; 19(4):e1003954. PubMed ID: 35385471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with quality of life in patients with kidney failure managed conservatively and with dialysis: a cross-sectional study.
    So S; Brown MA; Li K
    BMC Nephrol; 2023 Oct; 24(1):322. PubMed ID: 37891520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE.
    Roger SD; Jassal SV; Woodward MC; Soroka S; McMahon LP
    Int Urol Nephrol; 2014 Feb; 46(2):469-75. PubMed ID: 23982766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of C.E.R.A. in Routine Clinical Practice for Correction of Anaemia and Maintenance of the Haemoglobin Levels in CKD Patients not on Dialysis.
    Promod PJ; Deshpande R; Mohanty NK; Kulkarni S; Shah HA; Ganju A; Kukreja A; Joshi S
    J Assoc Physicians India; 2017 Mar; 65(3):52-57. PubMed ID: 28462544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK survey of patient and caregiver perspectives on the impact of chronic kidney disease-associated anaemia.
    Hull KL; Reast J; Clair C; Kent J; Moore M; Pittaway S; Revell P; Burton JO
    BMJ Open; 2024 Aug; 14(8):e087802. PubMed ID: 39153778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Collister D; Komenda P; Hiebert B; Gunasekara R; Xu Y; Eng F; Lerner B; Macdonald K; Rigatto C; Tangri N
    Ann Intern Med; 2016 Apr; 164(7):472-8. PubMed ID: 26881842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis.
    Kawahara K; Minakuchi J; Yokota N; Suekane H; Tsuchida K; Kawashima S
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():29-32. PubMed ID: 26456375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.
    Hung SC; Kuo KL; Tarng DC; Hsu CC; Wu MS; Huang TP
    Nephrology (Carlton); 2014 Dec; 19(12):735-9. PubMed ID: 25156587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials.
    Eckardt KU; Agarwal R; Farag YM; Jardine AG; Khawaja Z; Koury MJ; Luo W; Matsushita K; McCullough PA; Parfrey P; Ross G; Sarnak MJ; Vargo D; Winkelmayer WC; Chertow GM
    Nephrol Dial Transplant; 2021 Nov; 36(11):2039-2048. PubMed ID: 33188693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.
    Carrero JJ; Bárány P; Yilmaz MI; Qureshi AR; Sonmez A; Heimbürger O; Ozgurtas T; Yenicesu M; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2012 Feb; 27(2):709-15. PubMed ID: 21617198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients: A Hospital-Based Cross-Sectional Study.
    Sharma S; Kalra D; Rashid I; Mehta S; Maity MK; Wazir K; Gupta S; Ansari SA; Alruqi OS; Khan R; Khan I; Anwar S
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893506
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents.
    Io H; Aizawa M; Funabiki K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():7-13. PubMed ID: 26439537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review.
    Akizawa T; Okumura H; Alexandre AF; Fukushima A; Kiyabu G; Dorey J
    Ther Apher Dial; 2018 Oct; 22(5):444-456. PubMed ID: 30022586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
    Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
    Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic renal dysfunction and anaemia are associated with cognitive impairment in older patients with heart failure.
    Pulignano G; Del Sindaco D; Di Lenarda A; Tinti MD; Tarantini L; Cioffi G; Tolone S; Pero G; Minardi G
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):481-90. PubMed ID: 24983268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.